pneumocandin a(0) has been researched along with l 687781 in 2 studies
| Studies (pneumocandin a(0)) | Trials (pneumocandin a(0)) | Recent Studies (post-2010) (pneumocandin a(0)) | Studies (l 687781) | Trials (l 687781) | Recent Studies (post-2010) (l 687781) |
|---|---|---|---|---|---|
| 19 | 0 | 3 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzo, G; Balkovec, J; Bartizal, K; Hammond, M; Krupa, D; Nollstadt, K; Schmatz, D; Schwartz, R; Trainor, C; Vanmiddlesworth, F | 1 |
| Fromtling, RA; Nollstadt, KH; Pittarelli, LA; Romancheck, MA; Schmatz, DM; Schwartz, RE; Turner, MJ; Vanmiddlesworth, FL; Wilson, KE | 1 |
2 other study(ies) available for pneumocandin a(0) and l 687781
| Article | Year |
|---|---|
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Azoles; beta-Glucans; Candida albicans; Candidiasis; Echinocandins; Glucans; Kidney; Lethal Dose 50; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrans | 1992 |
Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Disease Models, Animal; Echinocandins; Glucans; Lung; Male; Peptides; Peptides, Cyclic; Pneumocystis; Pneumonia, Pneumocystis; Pyrans; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim | 1990 |